The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

[1] Rastogi P(2008)Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol. 26 778-785

[2] Anderson SJ(2007)Neoadjuvant chemotherapy for operable breast cancer Br J Surg. 94 1189-1200

[3] Bear HD(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol. 19 4224-4237

[4] Geyer CE(2008)Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results AJR Am J Roentgenol. 191 1331-1338

[5] Kahlenberg MS(2008)Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial J Natl Cancer Inst. 100 542-551

[6] Robidoux A(2007)Primary systemic chemotherapy of invasive lobular carcinoma of the breast Lancet Oncol. 8 55-62

[7] Mieog JS(2003)Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma Eur J Surg Oncol. 29 361-367

[8] van der Hage JA(2005)Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J Clin Oncol. 23 41-48

[9] van de Velde CJ(2006)Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol. 17 1228-1233

[10] van der Hage JA(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA. 98 10869-10874

[1] Rastogi P(2008)Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol. 26 778-785

[2] Anderson SJ(2007)Neoadjuvant chemotherapy for operable breast cancer Br J Surg. 94 1189-1200

[3] Bear HD(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol. 19 4224-4237

[4] Geyer CE(2008)Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results AJR Am J Roentgenol. 191 1331-1338

[5] Kahlenberg MS(2008)Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial J Natl Cancer Inst. 100 542-551

[6] Robidoux A(2007)Primary systemic chemotherapy of invasive lobular carcinoma of the breast Lancet Oncol. 8 55-62

[7] Mieog JS(2003)Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma Eur J Surg Oncol. 29 361-367

[8] van der Hage JA(2005)Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J Clin Oncol. 23 41-48

[9] van de Velde CJ(2006)Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol. 17 1228-1233

[10] van der Hage JA(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA. 98 10869-10874